Theocharis Panaretakis

8PUBLICATIONS
23CO-AUTHORS
Radiation therapyPredictive and prognostic markersLiquid biopsiesMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 26, 2025
Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment.

Paul G Corn, Guoyu Yu, Yibo Fan

|Jul 27, 2024
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice.

Song-Chang Lin, Guoyu Yu, Paul G Corn

|Nov 06, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer.

Emanuela Gentile, Andrew W Hahn, Jian H Song

|Jul 08, 2022
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.

Guoyu Yu, Paul G Corn, Pengfei Shen

|Jun 24, 2022
ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment.

Dimitrios Chioureas, Janina Beck, George Baltatzis

|Mar 23, 2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.

Ioulia Vardaki, Paul Corn, Emanuela Gentile

Pageof 2

Frequent Collaborators

3 joint publications

Christopher J Logothetis

2 joint publications

Sue-Hwa Lin

2 joint publications

Nora M Navone

1 joint publications

Cristian Coarfa